CNS Stock Analysis: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$64.14
-0.12 (-0.19%)
▼
5d:
-1.7%
30d:
+2.17%
90d:
-7.75%
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Apr 15, 2026
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CNS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CNS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$100.24
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$62.24
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $64.14, which is considered slightly low relative to its 30-day fair value range of $63.96 to $68.46. The stock's valuation (Forward PE: 17.4) is in line with its historical norms (19.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CNS is in a downtrend. The price is currently testing key support at $63.35. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $72.00 (+12.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CNS is in a downtrend. The price is currently testing key support at $63.35. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $72.00 (+12.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$63.96 -
$68.46
Company Quality Score
56/100
(HOLD)
Options IV Signal
14th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
81.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 14th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($72.00)
Fair Price Analysis
30-Day Fair Range
$63.96 -
$68.46
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$2.38
(3.7%)
Support & Resistance Levels
Support Level
$63.35
Resistance Level
$70.62
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
17.38
Wall Street Target
$72.00
(+12.0%)
Revenue Growth (YoY)
2.9%
Earnings Growth (YoY)
-23.4%
Profit Margin
27.6%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
17.4 vs 19.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$62.46
(-3%)
2-Year Target
$60.71
(-6%)
3-Year Target
$59.01
(-8%)
3-Yr Target (if PE normalizes)
(PE: 17→19)
$64.50
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 10.8%)
$112.10
(+74%)
Base:
(SPY PE: 17.4, Growth: 10.8%)
$87.38
(+36%)
Bear:
(PE: 14.8, Growth: 10.8%)
$74.28
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 21.53 | Current EPS (TTM): $2.97
Bull Case
$87.56
(+36%)
Analyst growth 24.5%, PE expands to 23.7
Base Case
$79.60
(+24%)
Market implied 24.5%, PE stable at 21.5
Bear Case
$43.49
(-32%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.4 to 19.0
Stabilization Target:
$70.24
(+9.3%)
PE Expansion Potential:
+9.3%
Last updated: February 02, 2026 12:24 PM ET
Data refreshes hourly during market hours. Next update: 1:24 PM
Data refreshes hourly during market hours. Next update: 1:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1334 | 59 HOLD |
|
HASI
Hannon Armstrong Sustain… |
STRONG BUY
16 analysts |
$40 | 63 BUY |
|
APO
Apollo Global Management… |
STRONG BUY
19 analysts |
$165 | 56 HOLD |
|
CRBG
Corebridge Financial Inc. |
STRONG BUY
14 analysts |
$38 | 66 BUY |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$174 | 52 HOLD |
